The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry

In patients with myelodysplastic syndrome (MDS), the prognostic significance of chromosome 17 abnormalities has not yet been fully elucidated, except for isochromosome 17q that has been characterized as an intermediate risk abnormality in the Revised International Prognostic Scoring System (IPSS‐R)....

Descripción completa

Detalles Bibliográficos
Autores principales: Diamantopoulos, Panagiotis, Koumbi, Dafni, Kotsianidis, Ioannis, Pappa, Vasiliki, Symeonidis, Argiris, Galanopoulos, Athanasios, Zikos, Panagiotis, Papadaki, Helen A., Panayiotidis, Panayiotis, Dimou, Maria, Hatzimichael, Eleftheria, Vassilopoulos, George, Delimpasis, Susan, Mparmparousi, Despoina, Papageorgiou, Sotirios, Variami, Eleni, Kyrtsonis, Marie‐Christine, Megalakaki, Aekaterini, Kotsopoulou, Maria, Repousis, Panagiotis, Adamopoulos, Ioannis, Kontopidou, Flora, Christoulas, Dimitrios, Kourakli, Alexandra, Tsokanas, Dimitrios, Konstantinos Papoutselis, Menelaos, Kyriakakis, Georgios, Viniou, Nora‐Athina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536924/
https://www.ncbi.nlm.nih.gov/pubmed/30897290
http://dx.doi.org/10.1002/cam4.2090

Ejemplares similares

Ejemplares similares